712 related articles for article (PubMed ID: 16865275)
1. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
[TBL] [Abstract][Full Text] [Related]
2. [Effect of rAAV-mediated RNA interference against EB virus-encoded latent membrane protein 1 on nasopharyngeal carcinoma cell proliferation and metastasis in nude mice].
Liu X; Liu X; Li G; Zhang B; Wang L; Li XH; Li XP
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):611-4. PubMed ID: 19403376
[TBL] [Abstract][Full Text] [Related]
3. [Influence of suppression of Epstein-Barr Virus-encoded latent membrane protein 1 by rAAV vector mediated RNA interference on metastatic ability of nasopharyngeal cancer cells in vivo].
Liu X; Li G; Zhang B; Wang L; Li XH; Li XP
Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):324-9. PubMed ID: 19799078
[TBL] [Abstract][Full Text] [Related]
4. Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells.
Li XP; Li G; Peng Y; Kung HF; Lin MC
Biochem Biophys Res Commun; 2004 Feb; 315(1):212-8. PubMed ID: 15013447
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
6. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of EBV-encoded LMP-1 by DNA-based RNA interference affects metastatic ability of nasopharyngeal carcinoma cells].
Li G; Li XP; Liu X; Peng Y; Lin MC
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):724-7. PubMed ID: 17366780
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
[TBL] [Abstract][Full Text] [Related]
9. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
Chen CL; Ou DL
Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
[TBL] [Abstract][Full Text] [Related]
10. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
[TBL] [Abstract][Full Text] [Related]
11. [Inhibiting target gene expression and controlling growth of Epstein-Barr virus transformed cells by antisense RNA transcripts].
Chen JJ; Raab-Traub N; Yao QY; Zhang F; Huang ML; Kuang ZJ; Zhang XS; Ye YL; Gu L
Ai Zheng; 2002 Jan; 21(1):16-20. PubMed ID: 12500390
[TBL] [Abstract][Full Text] [Related]
12. Molecular diagnosis of nasopharyngeal carcinoma using detection of Epstein-Barr virus latent membrane protein-1 gene in cervical metastatic lymph nodes.
Khademi B; Mahmoudi J; Monabati A; Maghsoudi B; Ashraf MJ; Mohammadianpanah M; Tabibi N; Valibeigi B; Abedi E
Am J Otolaryngol; 2009; 30(2):95-100. PubMed ID: 19239950
[TBL] [Abstract][Full Text] [Related]
13. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma.
Yoshizaki T; Horikawa T; Qing-Chun R; Wakisaka N; Takeshita H; Sheen TS; Lee SY; Sato H; Furukawa M
Clin Cancer Res; 2001 Jul; 7(7):1946-51. PubMed ID: 11448908
[TBL] [Abstract][Full Text] [Related]
14. [Recombinant AAV-LMP-induced LMP specific cytotoxic response to autologous lymphoblastoid cell lines tranformed by Epstein-Barr virus].
Zhao F; Liu H; Zhou L; Cai W; Du B; Ye S; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):247-51. PubMed ID: 15617340
[TBL] [Abstract][Full Text] [Related]
15. Tumor formation in nude mice inoculated with cultured human epithelial cells co-expressing Epstein-Barr virus latent membrane protein 1 and Bcl-2.
Lu JJ; Lay JD
Intervirology; 2007; 50(6):454-60. PubMed ID: 18268409
[TBL] [Abstract][Full Text] [Related]
16. Effect of inhibition of EBV-encoded latent membrane protein-1 by small interfering RNA on EBV-positive nasopharyngeal carcinoma cell growth.
Li G; Li XP; Peng Y; Liu X; Li XH
Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):241-6. PubMed ID: 15041532
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
18. Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity.
Seto E; Ooka T; Middeldorp J; Takada K
Cancer Res; 2008 Feb; 68(4):1030-6. PubMed ID: 18281477
[TBL] [Abstract][Full Text] [Related]
19. Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo.
Sheu LF; Chen A; Meng CL; Ho KC; Lee WH; Leu FJ; Chao CF
J Pathol; 1996 Nov; 180(3):243-8. PubMed ID: 8958799
[TBL] [Abstract][Full Text] [Related]
20. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]